Literature DB >> 7139611

Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells.

W Spinelli, K H Sonnenfeld, D N Ishii.   

Abstract

The effect of phorbol ester tumor promoters on neurite outgrowth was studied in cultured human neuroblastoma cell lines and in cultured embryonic chick and neonatal rat sympathetic ganglia. Promoters inhibited nerve growth factor (NGF)-stimulated neurite outgrowth in sympathetic ganglia while nonpromoting structural congeners did not, in keeping with previous results in embryonic sensory ganglia. In contradistinction, promoters reversibly enhanced neurite outgrowth in malignant SH-SY5Y neuroblastoma cells, whereas nonpromoting congeners were inactive. The potent promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) reversibly increased the proportion of SH-SY5Y cells with neurites and the average length of neurites; the effects of the combination of TPA and NGF were greater than that of either compound alone. The half-maximum response to TPA was at about 2 ng/ml (3 nM). The neurites were thinner, straighter, and less branched and showed more swellings resembling beads or varicosities in comparison with NGF-induced neurites. TPA transiently inhibited the cellular growth rate between Days 2 and 4. Thereafter, the rate was the same as in untreated cultures. The transient inhibition was due to causes other than degradation of TPA since fresh TPA was added. The effect of TPA on neurite outgrowth was not transient and was independent of effects on growth. TPA also enhanced neurite outgrowth in another NGF responsive line, LA-N-5, but not in two unresponsive lines, CHP-100 and CHP-134.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139611

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells.

Authors:  Sayed Hossein Hashemi; Jia-Yi Li; Håkan Ahlman; Annica Dahlström
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

2.  Influence of cyclic AMP and serum factors upon expression of a retinoid-responsive gene in neuroblastoma cells.

Authors:  A K Hall
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

3.  Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.

Authors:  J Garcia de Yebenes; J Yebenes; M A Mena
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

4.  Protein kinase inhibitors block neurite outgrowth from explants of goldfish retina.

Authors:  A M Heacock; B W Agranoff
Journal:  Neurochem Res       Date:  1997-10       Impact factor: 3.996

5.  Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y.

Authors:  N La Monica; V R Racaniello
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines.

Authors:  C Missale; A Codignola; S Sigala; A Finardi; M Paez-Pereda; E Sher; P F Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

7.  Insulin and insulin-like growth factor II permit nerve growth factor binding and the neurite formation response in cultured human neuroblastoma cells.

Authors:  E Recio-Pinto; F F Lang; D N Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Expression of CD44 is repressed in neuroblastoma cells.

Authors:  E Shtivelman; J M Bishop
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  AFAP120 regulates actin organization during neuronal differentiation.

Authors:  Xiaohua Xu; Jennifer Harder; Daniel C Flynn; Lorene M Lanier
Journal:  Differentiation       Date:  2008-10-16       Impact factor: 3.880

10.  Nerve growth factor modulates tubulin transcript levels in pheochromocytoma PC12 cells.

Authors:  P Fernyhough; D N Ishii
Journal:  Neurochem Res       Date:  1987-10       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.